Amarex logo

Amarex-sponsored Team Awarded Gold Medal at the 2018 iGEM Competition

Germantown, MD, USA (February 13, 2019) – Amarex is pleased to announce that its sponsored team, NTHU_Formosa, was awarded a gold medal at the 2018 International Genetically Engineered Machine Competition (iGEM), held at the Massachusetts Institute of Technology (MIT) in Boston, MA.

Team NTHU_Formosa, comprised of 14 undergraduate students and two PIs from the National Tsing Hua University in Taiwan, received a Gold medal for Integrated Human Practice and Model Your Project, a Silver medal for Validated Part/Validated Contribution, Collaboration, and Human Practices and a Bronze medal for Registration and Attendance, Competition Deliverables, Attribution and Contribution. The team also received nominations for Best Diagnostics Project and Best Presentation. NTHU_Formosa designed a wearable medical device called BioWatcher, which is a bioluminescent-detecting smart watch that tracks biomarker abnormalities in real-time and alerts the wearer of possible heath concerns. BioWatcher also has the capability of capturing this data for public health research studies. For more information on this project, please visit: http://2018.igem.org/Team:NTHU_Formosa.

Amarex President & CEO, Dr. Kazem Kazempour, stated that, “Amarex is grateful to have had the opportunity to sponsor NTHU_Formosa in their endeavor to enhance digital health care through application of the latest research and technology, and we are thrilled that the team earned a gold medal for their hard work and dedication. We are committed to supporting programs, such as the iGEM Competition, that offer unique learning experiences and collaboration to our future scientists.”

The iGEM Competition is supported by the iGEM Foundation, an independent, non-profit organization aimed at advancing the field of synthetic biology through education, friendly competition and collaboration. To learn more about the iGEM Competition or the IGEM Foundation, please visit: https://igem.org.

About Amarex Clinical Research

Amarex is a global, full service Contract Research Organization (CRO), whose leadership team has significant expertise conducting biomedical research, and whose combined experience includes the design and conduct of several hundred clinical research projects in many therapeutic indications. Amarex provides comprehensive services in Project Management (Phase I-IV, BE/BA, PK/PD), Regulatory Affairs, FDA Applications and Submissions, Applications and Submissions to international Health Authorities, GxP Compliance Audits, Clinical Operations, Adaptive Study Designs, Statistical Analysis, Data Management and General Consulting. Amarex has taken clients’ products through the entire approval process from writing the initial product approval strategy to the marketing approval application with a growing list of approved products. Amarex is committed to cost effective, high quality clinical product development.

Contact:
Patrick J. Burke
Business Development
patrickb@amarexcro.com

20201 Century Blvd., Fourth Floor
Germantown, MD 20874 USA
301 528 7000
www.amarexcro.com

Contact Us

Book a meeting or send us a message to talk to one of our experts.